HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has received its first significant purchase order since the onset of the global pandemic from a longstanding United Arab Emirates customer. The PO (“PO”) totaled $216,000 and, more importantly, may indicate the return of international sales after a COVID-19 slowdown. Before COVID-19, the multibillion-dollar Dubai-based company regularly placed multiple orders of similar size, establishing itself as one of HempFusion’s longest-standing international customers; the company distributes products throughout the Middle East, primarily in the United Arab Emirates. In addition, HempFusion announced plans to release financial results for Q1 2021, the period ending March 31, 2021. The company announced that it will release those numbers on Monday, May 17, 2021, at 4 p.m. ET. The company also scheduled a conference call to discuss the results; the conference call will be held the same day, May 17, 2021, at 4:15 p.m. ET. The call will also be available as a webcast and will include a question-and-answer period. Interested individuals can participate in the call by dialing 888-506-0062 domestically or 973-528-0011 internationally; the participant code is 795055. A replay of the call will be available on the company website in the investor section.
To join the webcast, visit https://ibn.fm/v4Qfh
To view the full press releases, visit https://ibn.fm/gzdp3 and https://ibn.fm/i1VBw
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://ibn.fm/CBDHF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
